| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.19▼ | 2.13▲ | 2.14▲ | 2.26▼ | 2.24▼ |
| MA10 | 2.18▲ | 2.13▲ | 2.15▲ | 2.31▼ | 2.23▼ |
| MA20 | 2.14▲ | 2.13▲ | 2.17▲ | 2.24▼ | 2.04▲ |
| MA50 | 2.13▲ | 2.20▼ | 2.27▼ | 2.21▼ | 2.32▼ |
| MA100 | 2.16▲ | 2.28▼ | 2.26▼ | 1.99▲ | 2.11▲ |
| MA200 | 2.22▼ | 2.26▼ | 2.16▲ | 2.12▲ | 2.14▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.010▲ | 0.006▲ | -0.011▼ | 0.048▲ |
| RSI | 61.046▲ | 54.155▲ | 47.684▼ | 47.759▼ | 52.295▲ |
| STOCH | 81.088▲ | 58.257 | 50.722 | 47.023 | 59.880 |
| WILL %R | -30.000 | -18.182▲ | -18.182▲ | -67.391 | -45.440 |
| CCI | 72.559 | 165.096▲ | 123.410▲ | -119.342▼ | 45.475 |
|
Saturday, September 06, 2025 05:00 AM
PRQR is a pre-clinical biotech with a novel RNA-editing platform, a clean balance sheet, and a focused pipeline. Read why PRQR remains a highly speculative investment.
|
|
Thursday, August 14, 2025 02:30 AM
HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions, today announced the dual listing of its common stock on NYSE Texas, the ...
|
|
Thursday, July 31, 2025 01:36 PM
July 31 (Reuters) - AT&T (T.N), opens new tab will dual list on the NYSE Texas, the U.S. wireless carrier said on Thursday, marking the latest company to be drawn to the Lone Star state's pro-business ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/09/25 | 2.16 | 2.215 | 2.04 | 2.19 | 472,347 |
| 11/09/25 | 2.25 | 2.25 | 2.10 | 2.19 | 403,693 |
| 10/09/25 | 2.31 | 2.32 | 2.17 | 2.25 | 260,688 |
| 09/09/25 | 2.29 | 2.335 | 2.26 | 2.33 | 377,810 |
| 08/09/25 | 2.48 | 2.48 | 2.205 | 2.33 | 432,261 |
| 05/09/25 | 2.43 | 2.50 | 2.36 | 2.45 | 374,449 |
| 04/09/25 | 2.45 | 2.4896 | 2.28 | 2.39 | 299,992 |
| 03/09/25 | 2.27 | 2.49 | 2.22 | 2.43 | 561,262 |
| 02/09/25 | 2.24 | 2.33 | 2.2201 | 2.29 | 446,805 |
| 29/08/25 | 2.20 | 2.25 | 2.13 | 2.25 | 152,458 |
|
|
||||
|
|
||||
|
|